1. Home
  2. BEAM vs CLBK Comparison

BEAM vs CLBK Comparison

Compare BEAM & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$23.08

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo Columbia Financial Inc.

CLBK

Columbia Financial Inc.

N/A

Current Price

$11.18

Market Cap

2.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BEAM
CLBK
Founded
2017
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.9B
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
BEAM
CLBK
Price
$23.08
$11.18
Analyst Decision
Strong Buy
Buy
Analyst Count
15
3
Target Price
★ $49.85
$14.17
AVG Volume (30 Days)
1.8M
★ 3.0M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
★ 1.78%
EPS Growth
★ 82.31
N/A
EPS
N/A
★ 0.14
Revenue
★ $24,000.00
N/A
Revenue This Year
N/A
$62.85
Revenue Next Year
N/A
$43.10
P/E Ratio
★ N/A
$80.43
Revenue Growth
★ 33.33
N/A
52 Week Low
$20.23
$10.51
52 Week High
$38.26
$25.83

Technical Indicators

Market Signals
Indicator
BEAM
CLBK
Relative Strength Index (RSI) 40.33 53.51
Support Level $22.65 $10.61
Resistance Level $28.19 $11.86
Average True Range (ATR) 1.92 0.28
MACD -0.33 0.06
Stochastic Oscillator 0.07 73.22

Price Performance

Historical Comparison
BEAM
CLBK

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.

Share on Social Networks: